Stockscreener 앱 받기
17.09
0.41%
-0.07
시간 외 거래:
17.09
Bausch Lomb Corp 주식(BLCO)의 최신 뉴스
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18 - The AI Journal
Nicox Announces Conference Attendance in H1 2026 and Upcoming Scientific Data Presentations - GlobeNewswire Inc.
Stifel reiterates Hold rating on Bausch & Lomb stock amid competition concerns By Investing.com - Investing.com Nigeria
Stifel reiterates Hold rating on Bausch & Lomb stock amid competition concerns - Investing.com Nigeria
Bausch + Lomb Corporation (NYSE:BLCO) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Aug Patterns: Will Bausch Lomb Corporation outperform its industry peersJuly 2025 Earnings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating Growth in the Healthcare Sector - DirectorsTalk Interviews
Goldman Sachs Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Raises Target Price to $19 - 富途牛牛
Intraocular Lens Market Size to Reach USD 9.85 Billion by 2033, Growing at a CAGR of 6.48% - GlobeNewswire Inc.
Published on: 2026-01-09 11:41:10 - Улправда
Will Bausch + Lomb Corporation (S2L) stock benefit from Fed rate cutsProduct Launch & Safe Entry Momentum Tips - ulpravda.ru
Bausch + Lomb (NYSE:BLCO) Rating Lowered to "Hold" at Evercore ISI - MarketBeat
Bausch + Lomb (NYSE:BLCO) Valuation Check After Mixed 90 Day And 1 Year Shareholder Returns - Yahoo Finance
Evercore Downgrades Bausch + Lomb Corp.(BLCO.US) to Hold Rating, Cuts Target Price to $18 - 富途牛牛
Bausch + Lomb Corporation (BLCO): Investor Outlook on Growth Potential and Strategic Positioning - DirectorsTalk Interviews
Glaucoma stories and research drive new Bausch + Lomb awareness push - Stock Titan
Bausch & Lomb CorpEnters fourth amendment to credit agreement dated as of May 10, 2022SEC filing - marketscreener.com
Bausch + Lomb just refinanced $2.8B in debt to cut interest margin - Stock Titan
Bausch + Lomb Signs Fourth Amendment to Credit Agreement With JPMorgan Chase and Lenders - TradingView — Track All Markets
Bausch + Lomb (BLCO): Investor Outlook on a Visionary Healthcare Player with a Focused Growth Trajectory - DirectorsTalk Interviews
Does Bausch + Lomb’s Rising Focus on Eye Health Make Its Current Share Price Attractive? - simplywall.st
Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Top eye-care leaders to speak at J.P. Morgan's big healthcare event - Stock Titan
[8-K/A] Bausch & Lomb Corp Amends Material Event Report | BLCO SEC FilingForm 8-K/A - Stock Titan
Bausch + Lomb Makes Key Appointments to Board of Directors - VisionMonday.com
Bausch + Lomb Corporation (NYSE:BLCO) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Will Bausch + Lomb Corporation stock keep outperforming rivalsMarket Trend Summary & Reliable Breakout Forecasts - Улправда
Published on: 2025-12-18 17:17:15 - Улправда
Icahn Money Manager Sues His Bosses and Bausch + Lomb Over Anti-White Bias - Insurance Journal
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year - The Globe and Mail
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans - VisionMonday.com
Bausch + Lomb appoints two new directors to board effective January - Investing.com
Bausch + Lomb Adds New Directors to Board - TipRanks
Bausch & Lomb Corp Announces Board Appointments - TradingView — Track All Markets
Bausch + Lomb appoints two new directors to board effective January By Investing.com - Investing.com South Africa
Bausch + Lomb (NYSE: BLCO) appoints Eduardo Alfonso and Steven Collis to board - Stock Titan
Bausch + Lomb Brief: Appointing Eduardo C. Alfonso, and Steven H. Collis To Its Board, Effective Jan. 1, 2026; Board Will Then Be Comprised of 10 Directors - marketscreener.com
Bausch + Lomb Announces Two Board Of Directors Appointments - TradingView — Track All Markets
Leading eye specialist and Fortune 10 CEO join Bausch + Lomb board - Stock Titan
Bausch + Lomb Corporation's (NYSE:BLCO) Prospects Need A Boost To Lift Shares - 富途牛牛
Large-Scale Debt Refinancing And Pipeline Optimism Might Change The Case For Investing In Bausch + Lomb (BLCO) - simplywall.st
(BLCO) Strategic Equity Report (BLCO:CA) - news.stocktradersdaily.com
America First Legal Files Lawsuit Against Bausch + Lomb for Racial Discrimination in Board Appointments - America First Legal
Icahn money manager sues his bosses and Bausch + Lomb over anti-white bias - MSN
Bausch + Lomb: I Need To See Stability Before Upgrading This Name (BLCO) - Seeking Alpha
Nomura Holdings Inc. Cuts Holdings in Bausch + Lomb Corporation $BLCO - MarketBeat
Bausch + Lomb (NYSE:BLCO) valuation after analyst upgrades highlight confidence in growth and margin improvement - simplywall.st
Bausch + Lomb allocates $2.8 bln in new term loans to refinance existing debt - MSN
How Bausch + Lomb’s $2.8 Billion Refi and Eye-Care Pipeline Momentum Will Impact Bausch + Lomb (BLCO) Investors - Yahoo Finance
(BLCO) Stock Trading Blueprint (BLCO:CA) - news.stocktradersdaily.com
3.46%
0.17%
자본화:
|
볼륨(24시간):